Yoshinori Minami
Overview
Explore the profile of Yoshinori Minami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Kikuchi H, Sakakibara-Konishi J, Furuta M, Yokouchi H, Nishihara H, Yamazaki S, et al.
Oncotarget
. 2017 Jan;
8(6):10348-10358.
PMID: 28060745
Notch signaling in tumorigenesis functions as an oncogene or tumor suppressor according to the type of malignancy. Numb represses intracellular Notch signaling. Previous studies have demonstrated that Notch signaling suppresses...
22.
Yokouchi H, Nishihara H, Harada T, Ishida T, Yamazaki S, Kikuchi H, et al.
Oncotarget
. 2017 Jan;
8(24):39711-39726.
PMID: 28055980
The limited number of available treatments for patients with small-cell lung cancer (SCLC) has prompted us to further investigate the biology of SCLC by molecular profiling. We collected formalin-fixed paraffin-embedded...
23.
Yokouchi H, Ishida T, Yamazaki S, Kikuchi H, Oizumi S, Uramoto H, et al.
Lung Cancer
. 2015 Nov;
90(3):548-53.
PMID: 26604032
Objectives: Several American and Japanese guidelines recommend surgery for patients with c-stage I small-cell lung cancer (SCLC), whereas the European Society of Medical Oncology (ESMO) guidelines recommend surgery for patients...
24.
Endo S, Sasaki T, Onishi K, Kazebayashi Y, Hirai N, Minami Y, et al.
Int J Antimicrob Agents
. 2015 Nov;
46(6):721-2.
PMID: 26597933
No abstract available.
25.
Endo S, Yamamoto Y, Minami Y, Okumura S, Sasaki T, Ohsaki Y
Respirol Case Rep
. 2015 Jun;
3(2):64-7.
PMID: 26090114
Histamine H1 antagonists rarely cause drug-induced lung injury (DLI). A woman in her 60s, who had been taking antihistaminic levocetirizine for 2 months, presented with progressive cough and shortness of...
26.
Minami Y, Sasaki T, Bochimoto H, Kawabe J, Endo S, Hira Y, et al.
Int J Oncol
. 2014 Dec;
46(2):548-54.
PMID: 25434699
Prostaglandin I2 (PGI2) agonist has been reported to reduce tumor metastasis by modifying tumor angiogenesis; however, the mechanisms of how PGI2 affects the endothelial cells or pericytes in tumor vessel...
27.
Aburakawa Y, Kawabe J, Okada M, Yamauchi A, Asanome A, Kabara M, et al.
Circ J
. 2012 Dec;
77(4):1053-62.
PMID: 23257313
Background: Prostacyclin (PGI2) enhances angiogenesis, especially in cooperation with bone marrow (BM)-derived endothelial progenitor cells (EPCs). However, the mechanisms of PGI2 in EPC-mediated angiogenesis in vivo remain unclear. The purpose...
28.
Minami Y, Endo S, Okumur S, Sasaki T, Yamamoto Y, Ogasa T, et al.
Nihon Kokyuki Gakkai Zasshi
. 2011 Dec;
49(11):793-9.
PMID: 22171481
A high-dose administration of inhaled corticosteroid is effective in the majority of patients with bronchial asthma, but is often difficult to attain sufficient control in certain subsets of patients. Omalizumab...
29.
Okumura S, Sasaki T, Minami Y, Ohsaki Y
J Thorac Oncol
. 2011 Nov;
7(1):49-56.
PMID: 22089115
Background: Non-small cell lung cancer (NSCLC) often has an epidermal growth factor receptor (EGFR) gene mutation. Growth of EGFR-gene-mutated NSCLC depends predominantly on EGFR signaling and requires a large amount...